Siddiqui Nazlee, Dwyer Mitchell, Stankovich Jim, Peterson Gregory, Greenfield David, Si Lei, Kinsman Leigh
Australian Institute of Health Services Management (AIHSM), Tasmanian School of Business and Economics, University of Tasmania, Rozelle campus, Cnr Glover and Church Streets, Sydney, NSW, 2039, Australia.
School of Health Sciences, University of Tasmania, Tasmania, Australia.
BMC Health Serv Res. 2018 Jun 27;18(1):498. doi: 10.1186/s12913-018-3316-2.
With the increasing burden of mental illness globally, it is becoming common for hospitalised patients with chronic medical conditions to have a comorbidity of mental illness. This combination could prolong length of stay (LOS) of this patient cohort. We conducted an investigation in Tasmania, Australian hospitals to characterise this cohort and assess if co-morbidity of mental illness is a distinguishing factor that generates LOS variation across different chronic medical conditions.
The retrospective study analysed 16,898 admissions of patients with a primary diagnosis of one of five chronic medical conditions: lung or colorectal cancer, chronic obstructive pulmonary disease (COPD), type II diabetes, ischaemic heart disease (IHD) and stroke. Data were from July 2010 to June 2015, across four hospitals that collectively cover 95% of public hospital admissions in Tasmania, Australia. Descriptive statistics were used to compare characteristics of patients between the scenarios of with and without co-morbidity of mental illness. We used negative binomial regression models to assess whether co-morbidity of mental illness, along with its sub-types, after adjustment for potential confounding variables, associated with LOS variation in patients of each medical condition. Based on the adjusted LOS variation, we estimated differences in bed days' use between patients with and without comorbidity of mental illness.
Patients with co-morbidity of mental illness were significantly younger in comparison to patients without mental illness. With each medical condition, patients with comorbidity of mental illness had incurred higher bed days' use than for those without mental illness. In cancer and stroke cohorts, co-morbidity of mental illness unfavourably affected the LOS variation by as high as 97% (CI: 49.9%-159%) and 109% (78%-146%), respectively. Though mental and behavioural disorders due to psychoactive substances was a dominant sub-type of mental illness across the medical conditions, it contributed significant unfavourable LOS variation only in the stroke patients i.e. 36.3% (CI: 16.2%-59.9%).
Mental illness consistently produced unfavourable LOS variation. Upskilling of healthcare teams and greater reporting and analysis of LOS variation for this patient cohort, and the sub-cohorts within it, are necessary to provide improved medical care and achieve system efficiencies.
随着全球精神疾病负担的增加,患有慢性疾病的住院患者合并精神疾病的情况日益普遍。这种合并情况可能会延长该患者群体的住院时间(LOS)。我们在澳大利亚塔斯马尼亚州的医院进行了一项调查,以描述该群体的特征,并评估精神疾病合并症是否是导致不同慢性疾病患者住院时间差异的一个显著因素。
这项回顾性研究分析了16898例主要诊断为以下五种慢性疾病之一的患者的入院情况:肺癌或结直肠癌、慢性阻塞性肺疾病(COPD)、II型糖尿病、缺血性心脏病(IHD)和中风。数据来自2010年7月至2015年6月,涵盖澳大利亚塔斯马尼亚州95%公立医院入院病例的四家医院。使用描述性统计方法比较有和没有精神疾病合并症的患者特征。我们使用负二项回归模型来评估在调整潜在混杂变量后,精神疾病合并症及其亚型是否与每种疾病患者的住院时间差异相关。根据调整后的住院时间差异,我们估计了有和没有精神疾病合并症的患者在病床使用天数上的差异。
与没有精神疾病的患者相比,患有精神疾病合并症的患者明显更年轻。对于每种疾病,患有精神疾病合并症的患者比没有精神疾病的患者使用的病床天数更多。在癌症和中风患者群体中,精神疾病合并症分别对住院时间差异产生了高达97%(CI:49.9%-159%)和109%(78%-146%)的不利影响。尽管在所有疾病中,精神活性物质所致精神和行为障碍是精神疾病的主要亚型,但它仅在中风患者中导致了显著的不利住院时间差异,即36.3%(CI:16.2%-59.9%)。
精神疾病始终会产生不利的住院时间差异。提高医疗团队的技能水平,以及对该患者群体及其子群体的住院时间差异进行更多的报告和分析,对于提供更好的医疗服务和提高系统效率是必要的。